An analysis of the forecasted mortality rate for pancreatic malignant neoplasms in Switzerland shows a steady increase from 2024 to 2028. The rate is projected to rise from 17.5 deaths per hundred thousand persons in 2024 to 18.3 in 2028. In 2023, the mortality rate stood at 17.3 deaths per hundred thousand persons, indicating an upward trend.
Over the last two years, the year-on-year percentage variation in mortality rates is approximately as follows:
- 2023 to 2024: 1.16%
- 2024 to 2025: 1.14%
When looking at the five-year period from 2024 to 2028, the compounded annual growth rate (CAGR) is approximately 1.12%, signifying a consistent annual increase in mortality rates.
Future trends to watch for include advancements in early detection and treatment of pancreatic cancer, potential changes in healthcare policy, and public health initiatives aimed at lifestyle changes. These factors could influence mortality rates in the coming years. Monitoring these trends will be crucial for projecting future mortality rates more accurately.
